Journal of the Korean Society of Food Culture (한국식생활문화학회지)

Korean Society of Food Culture (한국식생활문화학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Aluminum Feedings on Aluminum, Phospholipid and Catecholamine Concentrations in Old Rat Brain Tissue

알루미늄을 투여한 노령 흰쥐에 있어서 뇌조직의 인지질 구성과 신경전달 물질 농도에 미치는 영향

  • Han, Sung-Hee (Department of Food of Nutrition, Wonkwang Health Science College) ;
  • Choi, Deck-Ho (College of Pharmacy, Wonkwang University)
  • Published : 2009.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was performed to investigate the effects of aluminum sulfate administration on the brain tissues of old rats, when given at different concentrations. The experiment attempted to further ascertain whether aluminum exposure cause Alzheimer's disease. Seventy-five aged Sprague-Dawley rats were divided into five groups; a control group, 2 ppm aluminum sulfate group, 20 ppm aluminum sulfate group, 40 ppm aluminum sulfate group, and 200 ppm aluminum sulfate group, and were kept on the respective diets for 12 weeks. In order to understand the influence of aluminum on the brain, serum aluminum concentrations, phospholipid composition, and catecholamine concentrations were compared between the aluminum-treated groups and the normal group. According to the results, serum aluminum was higher in the aluminum sulfate-treated groups than in the normal group. Within the cortex, catecholamine concentrationes were significantly increased but cerebellum and brainstem tissue were significantly decreased, in the aluminum sulfate-treated groups compared to the normal group. For phospholipid composition, phosphatidyl inositol was significantly increased wherase phosphatidyl choline, phosphatidyl ethanolamine, and phosphatidyl serine were significantly decreased in the aluminum sulfate-treated groups versus the normal group. Based on the data, increased aluminum consumption in experimental animals causes increased serum aluminum levels and catecholamine variation. These phenomena are very similar to conditions of Alzherimer's disease. Therfore, the results of this experiment further suggest that aluminum cause Alzherimer's disease, coinciding with reports that aluminum is a cause of neurofibrilly tangles in the brain.

Keywords

References

  1. Alfrey AC. 1983. Aluminum. Advance in clinical chemistry, 23(10):69-91 https://doi.org/10.1016/S0065-2423(08)60398-4
  2. Akeson MA, Munns DN, Buran RG. 1989. Absorption of $ {Al}^{+3}$ to phosphatidylcholine versicles. Biochim Biophys Acta, 986(1):33-40 https://doi.org/10.1016/0005-2736(89)90269-1
  3. Andreoil SP, Bergstein JM, Sherrad JD. 1984. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. New England Journal of medicine, 31(17):1079-1084
  4. Beal MF, Mazurek MF, Ellison DW, Kowall NW, Solomon PR, Penelebury WW. 1989. Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits. Neuroscience, 29(2):339-346 https://doi.org/10.1016/0306-4522(89)90061-4
  5. Berlyne GM, Yagil R, Ari JB, Weinderger G, Knopf E, Danovicth GM. 1972. Aluminum toxicity in rats. Lancet, 11:546-568 https://doi.org/10.1016/S0140-6736(72)90357-1
  6. Bergmeyer HU. 1995. Methods of enzymatic analysis verlag chemie. Academic press weinheim, 1(2):20-28
  7. Bjorksten JA. 1982. Dietary aluminum and Alzheimer's disease. Sci Total Environ, 25(1):81-86 https://doi.org/10.1016/0048-9697(82)90044-4
  8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry, 72(1):248-254 https://doi.org/10.1016/0003-2697(76)90527-3
  9. Buyukysl RL, Richard JW. 1990. 4-Aminopyridine increase acetylcholine release without diminishing membrane phosphatidylcholine. J Neurochem, 54(4):1302-1309 https://doi.org/10.1111/j.1471-4159.1990.tb01963.x
  10. Candy JM, Oakley A, Klinowski J, Carpenter T, Perry R, Atack J, Perry E, Blessed G, Fairbairn A, Edwardson JA. 1986. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet, 15(1):354-357 https://doi.org/10.1016/S0140-6736(86)92319-6
  11. Chan YM, Wong R, Maclean L. 1983. Epidemiologic health study of workers in an aluminum smelter in British columbia. Am Rev Respir Dis, 127(4):465-469 https://doi.org/10.1164/arrd.1983.127.4.465
  12. Cheon YM, Chang YK, Baik TK. 1999. Evidence of memory improvement by phosphatidylcholine supplement at fetus and neonate. Kor J Nutr, 32(8):864-869
  13. Choi YH, Yoon SH, Hong HM, Kang YS, Chae KR, Lee JO. 2005. Monitoring of aluminum phospholipid residues in wheat and wheat flour. Korean J Food Sci Technol, 37(4): 532-536
  14. Crapper DR, Boni UD. 1983. Experimental and clinical neurotoxicology. Aluminum, 32(9):326-335
  15. Committee on nutrition. 1986. Aluminum toxicity in infants and children. Pediatrics, 78(6):1150-1160
  16. Davies P, Maloney AJF. 1976. Selective loss of central neurons in Alzheimer's disease. Lancet, 25(2):1403 https://doi.org/10.1016/S0140-6736(76)91936-X
  17. Deschamp V, Astier X, Ferry M, Rainfrary M, Emeriau JP. 2002. Nutritional status of health elderly persons living in Dordogne, France and realtion with mortality and cognitive or functional decline. Eur J Clin Nutr, 56(4):305-312 https://doi.org/10.1038/sj.ejcn.1601311
  18. Deloncel R, Guillard O. 1990. Mechanism of Alzeheimer's disease: argument for a neurotransmitter aluminum complex implication. Neurochem Res, 15(12):1239-1245 https://doi.org/10.1007/BF01208586
  19. Folch J, Lees M, Sloane-Stanley G. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem, 226(1):497-509
  20. Flaten TP, Alfrey AC, Birchall JD, Savory J, Yokel RA. 1996. States and future concerns of clinical and environmental aluminum toxicology. Toxicol Environ Health, 48(6):527-541 https://doi.org/10.1080/009841096161050
  21. Fraser GE, Singh PN, Bennett H. 1996. Variables associated with cognitives function in elderly california seventy day adventists. Am J Epidemiol,143(12):1181-1190 https://doi.org/10.1093/oxfordjournals.aje.a008705
  22. Gillian F, Paul A, Simon W, Ghose B, Lejeune J, Corbett J, Prasher V, Blair J. 1990. Defective gallium transferrin binding in alzheimer's disease and down syndrome;possible mechanism for accumulation of aluminium in brain. Lancet, 335(8719):745-750 https://doi.org/10.1016/0140-6736(90)90868-6
  23. Greger JL, Lane HW. 1987. The toxicology of dietary tin aluminum and selenium Ch 9. In nutritional toxicoligy vol II. Hathcock JN (Ed) Academic Press. New York. pp 223-230
  24. Growdon JH, Wurtman RJ. 1979. Dietary influences on the synthesis of neurotransmitters in the brain. Nutrition Rev, 37(5):129-136 https://doi.org/10.1111/j.1753-4887.1979.tb06649.x
  25. Goyer RA, Klaassen CD, Waalkes MP. 1995. Metal toxicology. Academic Press. London. pp 199-235
  26. Gupta A, Shulka GS. 1995. Effect of chronic aluminum exposure in the levels of conjugated dienes and enzymatic antioxidants in hippocampus and whole brain of rats. Bull Environ Contain Toxicol, 55(33):716-722
  27. Herman DR, Solomons NW, Mendoza I, Qureshi AK. 2001. Selfrated health and its realtionship to functional status and wellbeing in a group of elderly guatemalan subjects. Asia Pacifice J Clin Nutr, 10(3):176-182 https://doi.org/10.1046/j.1440-6047.2001.00245.x
  28. Jan KB, Gonzalez IL, Logue M, Growdon JH, Wurtman. RJ. 1990. Levels of phosphlipid catabolic intermediates glycerophosphocholine and glycerophos-phoetanolamine are elevated in brains of alzheimer's disease but not of down's syndrome patients. Brain Res, 536(17):240-244 https://doi.org/10.1016/0006-8993(90)90030-F
  29. Jack R, Rabin PL, Mckinney TD. 1983. Dialysis encephalpathy; a review. Int J Psychiat in Med, 13(4):309-326 https://doi.org/10.2190/C36R-6WGP-LCYU-9VRG
  30. Jope RS. 1982. Effects of phosphatidylcholine administration to rats on choline in blood and choline and acetylcholine in brain. J Pharmacology Exp Ther, 220(3):322-328
  31. Kang NE. 1993. A study on the influence of aging and nutrition on the cognitive function by the blood glucose level among elderly korean. Ewha Womans' University Doctal Thesis. pp 115-120
  32. Kavoussi LP, Laurence DG, Andriole GL. 1986. Encephalopathy and an elevated serum aluminum level in patients receving intravesical aluminum irrigation for severe urinary hemorrage. J Urol, 136(3):665-667 https://doi.org/10.1016/S0022-5347(17)45009-9
  33. Klein GL. 1990. Nutritional aspects of aluminum toxicity. Nutrition reserach review, 3(1):117-141 https://doi.org/10.1079/NRR19900009
  34. Kim JM, Ahn JM, Kim JI, Shin HR, Jung KY, Kim JY. 2000. Blood Lead, Manganess, Aluminum and silicon concentration in korean adults. Korean J Prev Med, 33(2):157-164
  35. Korean national statistical office. 2006. Annual report
  36. Krschbaum BB, Schoolwerth AC. 1989. Acute aluminum toxicity associated with oral citrate and aluminum containg antacids. American Journal Medical Science, 297(1):9-11 https://doi.org/10.1097/00000441-198901000-00003
  37. Lansberg JP, McDonald B, Watt F. 1992. Absence of aluminum in neurtic plague cores in Alzheimer's disease. Nature, 360(5):65-68 https://doi.org/10.1038/360065a0
  38. Last JM, Wallace RB, Connor EB, Fielding JE, Frank AL, Scutchfield FD, Tyler CW, Wenzel RP. 1998. Maxcy Rosenau-Last Public health & preventive medicine. Prenticehall international Inc. USA. 14:494-502
  39. Lee HS, Chang MJ. 1999. Effects of family type on the nutrient intake and nutritional status in elderly women. J Korean Soc Food Sci Nutr, 28(4):934-941
  40. Lee L, Kang SA, Lee HO, Lee BH. 2001. Relationships between dietary intake and cognitive function level in korean elderly people. Public Health, 115(2):133-138 https://doi.org/10.1016/S0033-3506(01)00432-2
  41. Lee HS. 1992. Analysis of aluminum concentration in serum and phospholipid composition and catecholamine concentration in the brain of rats fed aluminium in drinking water. Dept. of food & nutrition graduate school Sook Myung women's university
  42. Martyn CN, Barker DJP, Osmond C, Harris EC, Edwardson JA, Lacey RF. 1989. Geographical relation between alzeheimer's disease and aluminum in drinking water. Lancet, 14(1):59-62
  43. Merrill FE, Robbins MA, Schultz NR, Streeten DH, Penelope KE. 1987. Clinical significance of cognitive performance by hypertensive patients. Hypertension, 9(2):192-197 https://doi.org/10.1161/01.HYP.9.2.192
  44. Moon CJ, Koh HC, Shin IC, Lee EH, Moon HR. 2004. The effects of oxidative stress induced by aluminum on cellular macromolecules in the hippocampus and cerebral cortex of rats. J Toxicol Pub Health, 20(3):213-223
  45. Oh MH, Houghton PJ, Whang WK, Cho JH. 2004. Screening of korean herbal medicines used to improve cognitive function for anti-cholin esterase activity. Phytomedicine, 11(6):544-548 https://doi.org/10.1016/j.phymed.2004.03.001
  46. Park JS, Kang SA, Lee L, Kim JH, Jung IK, Park YJ, Lee JE. 1999. Associations between environmental factors and depression in korean elderly people. J of Arahe, 4(6):51-56
  47. Parkinson IS, Ward HK, Feest TG, Fawett RWP, Kerr DNS. 1979. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet, 24(1):406-409 https://doi.org/10.1016/S0140-6736(79)90883-3
  48. Price DL. 1986. New perspective on alzheimer's disease. Annu Rev Neurosci, 9(27):489-517 https://doi.org/10.1146/annurev.ne.09.030186.002421
  49. Perl DP, Brody AR. 1980, Alzherimer's disease; X-ray spectrometric evidence of aluminum accumulation in neurofibrillary evidence of aluminum accumulation in neurofibrillary tangle-bearing neuros. Science, 208(18):297-299 https://doi.org/10.1126/science.7367858
  50. Perry RH, Blessed G, Perry EK. 1980. Histochemical observations on cholinesterase activities on the brains of elderly normal and demented (Alzhermer-type) patients. Age-aging, 9(2):9-16 https://doi.org/10.1093/ageing/9.1.9
  51. Reeves PG, Nielson FH, Fahey GC. 1993. AIN-93 purified diets for laboratoary rodents finial report of the American institute of nutrition and hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr, 123(11):1939-1995
  52. Rue AL, Koehler CM, Wayne SJ, Chiulli SJ, Haland KY, Garry PJ. 1997. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr, 65(1):20-29
  53. Schulz V. 2003. Ginkgo extract or cholinesterase inhibitors in patients with dementia; what clinical trials and guidelines fail to considr. Phytomedicine, 10(4):74-79 https://doi.org/10.1078/1433-187X-00302
  54. Sedman AB, Wilkening GN, Bradeley PD, Warrady BA, Lum GM, Alfrey AC. 1984. Encephalopathy in childhood secondary to aluminum toxicity. Journal of pediatrics, 105(5):835-838
  55. Spencer H, Kramer L, Norris C. 1982. Effect of small doses of aluminum containing antacids on calcaium and phosphorus metabolism. Am J Clin Nutr, 36(1):32-40
  56. Steven AF, Buyukuysal RL, Wurtman RJ. 1990. Why do phospholipid levels decrease with repeated stimulation? A study of choline-containing compounds in rat striatum following electrical stimulation. Annal NY Acad Sci, 640(1):114-117
  57. William RM. 1977. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med, 23(1):134-147 https://doi.org/10.1016/S0891-5849(96)00629-6
  58. Vander VGB, Wolff FA. 1985. Distribution of aluminum between plasma and erythrocytes. Human Toxicol, 4(6):643-648 https://doi.org/10.1177/096032718500400613